Testing effectiveness (Phase 2)Study completedNCT01291420
What this trial is testing
Dendritic Cell Vaccination for Patients with Solid Tumors
Who this might be right for
GlioblastomaRenal Cell CarcinomaSarcomas+3 more
University Hospital, Antwerp 48